H.R. 4983

Referred to Committee

To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.

Introduced 4/18/2016•114th Congress•House

Latest Action

Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.

4/27/2016 • House

Summary

This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Introduced in House • 4/18/2016

Enter your district to see how this bill affects your community

Topics & Subjects

Policy Area: Health

Drug trafficking and controlled substancesDrug, alcohol, tobacco useHealth information and medical recordsHealth promotion and preventive careIndian social and development programsMinority healthPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (1)

Sponsor

Rep. Griffith, H. Morgan [R-VA-9]

Republican • VA-9

Bill Journey

Originated in the House

Introduced

April 18, 2016

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law